Antimicrobial resistance of Escherichia coli strains causing neonatal sepsis between 1998 and 2008

Chemotherapy
Elisabet GuiralSara M Soto

Abstract

Bloodstream infections are a significant cause of neonatal morbidity and death. An increase in the incidence of early neonatal sepsis due to Escherichia coli has been reported. The objective was to evaluate the antimicrobial resistance of E. coli strains causing early-onset neonatal sepsis (EONS) and late-onset neonatal sepsis (LONS) and their evolution. E. coli strains from EONS and hospital-acquired LONS collected at the Hospital Clinic of Barcelona were included in the study. No statistically significant differences in resistance profiles were found between strains causing EONS and LONS. An increase in the resistance to all the antimicrobial agents studied was observed for the period 2000-2008 in comparison with the 1985-1999 period, with the increase in resistance to gentamicin, piperacillin and tobramycin being statistically significant. Two strains carried the bla(CTX-M) genes (bla(CTX-M-14) and bla(CTX-M-15)). The increase in ampicillin and gentamicin resistance makes a change in the treatment of neonates necessary.

References

Sep 1, 1983·Archives of Disease in Childhood·M M Placzek, A Whitelaw
May 1, 1995·The Pediatric Infectious Disease Journal·J O Klein
Dec 1, 1994·American Journal of Obstetrics and Gynecology·M S Amstey
Feb 7, 1998·Archives of Pediatrics & Adolescent Medicine·T A JosephN Jacobs
Oct 28, 1998·American Journal of Obstetrics and Gynecology·C V TowersT Asrat
Jul 26, 2002·The New England Journal of Medicine·Barbara J StollW Kenneth Poole
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Vincent Perreten, Patrick Boerlin
Jul 17, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B GuerraM C Mendoza
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Nahid KaramiAgnes E Wold
Sep 29, 2006·The Pediatric Infectious Disease Journal·Stephanie J Schrag, Barbara J Stoll
Oct 24, 2007·Journal of Applied Microbiology·O L AkinbowaleM D Barton
Jun 28, 2008·The Journal of Antimicrobial Chemotherapy·Nahid KaramiAgnes E Wold
Jan 10, 2009·The Pediatric Infectious Disease Journal·Durrane ThaverAnita K M Zaidi
Jul 31, 2010·Paediatric and Perinatal Epidemiology·Pierre KuhnDominique Astruc
Sep 30, 2010·Archives of Disease in Childhood. Fetal and Neonatal Edition·Stefania VergnanoPaul T Heath

❮ Previous
Next ❯

Citations

Feb 19, 2014·Current Infectious Disease Reports·James W GrayPhilip Milner
Feb 4, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Emma Sáez-LópezSara M Soto
Jun 7, 2019·Acta Paediatrica·Daniel GlikmanUNKNOWN EOS Israeli study group
Aug 5, 2017·European Journal of Pediatrics·Natalia Mendoza-PalomarPere Soler-Palacin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.